Literature DB >> 26779444

Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Guang-Jian Liu1, Wei Wang1, Ming-De Lu2, Xiao-Yan Xie1, Hui-Xiong Xu1, Zuo-Feng Xu1, Li-Da Chen1, Zhu Wang1, Jin-Yu Liang1, Yang Huang1, Wei Li1, Jin-Ya Liu1.   

Abstract

PURPOSE AND METHODS: The ability of contrast-enhanced ultrasound (CEUS) to differentiate between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) is still controversial. We reviewed the CEUS imaging of 819 patients (HCC=546, ICC=273) with an established pathological diagnosis. The enhancement patterns of lesions and the diagnostic performance of CEUS were analyzed.
RESULTS: Arterial hyperenhancement followed by washout was observed in 92.3% (504/546) of the HCC lesions and 85.7% (234/273) of the ICC lesions on CEUS (p<0.05). Additionally, the ICCs presented contrast washout much earlier than the HCCs, with an average time of 27.5 seconds after injecting the contrast agent compared with 70.1 seconds for the HCCs (p<0.05). Peripheral rim-like enhancement was observed in 68.5% (187/273) of the ICCs, which was significantly more common than that in the HCCs (2.0%, 11/546) (p<0.05). When using arterial hyperenhancement with a washout phase later than 43 seconds after injecting the contrast agent and with no peripheral rim-like enhancement as the diagnostic criteria for HCC ≤5 cm in diameter, the area under the curve was 0.808, with 64.1% sensitivity, 97.4% specificity and 73.6% accuracy.
CONCLUSIONS: Although ICC may show the typical enhancement pattern of HCC on CEUS, peripheral rim-like enhancement and quick contrast washout show high efficiency in the differentiation of HCC from ICC.

Entities:  

Keywords:  Contrast-enhanced ultrasound; Differentiation; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma

Year:  2015        PMID: 26779444      PMCID: PMC4702012          DOI: 10.1159/000367738

Source DB:  PubMed          Journal:  Liver Cancer        ISSN: 1664-5553            Impact factor:   11.740


  32 in total

1.  Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.

Authors:  Emilio Quaia; Fabrizio Calliada; Michele Bertolotto; Sandro Rossi; Lorena Garioni; Laura Rosa; Roberto Pozzi-Mucelli
Journal:  Radiology       Date:  2004-08       Impact factor: 11.105

2.  Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC).

Authors:  A von Herbay; C Vogt; J Westendorff; D Häussinger; M Gregor
Journal:  Ultraschall Med       Date:  2009-12-07       Impact factor: 6.548

3.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

4.  Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.

Authors:  Alexandra von Herbay; Christoph Vogt; Reinhard Willers; Dieter Häussinger
Journal:  J Ultrasound Med       Date:  2004-12       Impact factor: 2.153

5.  Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.

Authors:  Ramón Vilana; Alejandro Forner; Luis Bianchi; Angeles García-Criado; Jordi Rimola; Carlos Rodríguez de Lope; María Reig; Carmen Ayuso; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

6.  Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.

Authors:  Su Jin Kim; Jeong Min Lee; Joon Koo Han; Ki Hyun Kim; Jae Young Lee; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2007-12       Impact factor: 3.959

7.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

8.  Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging.

Authors:  M D'Onofrio; F Vecchiato; V Cantisani; E Barbi; M Passamonti; P Ricci; R Malagò; N Faccioli; G Zamboni; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

9.  Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm.

Authors:  Hui-Xiong Xu; Xiao-Yan Xie; Ming-De Lu; Guang-Jian Liu; Zuo-Feng Xu; Yan-Lin Zheng; Jin-Yu Liang; Li-Da Chen
Journal:  J Clin Ultrasound       Date:  2008-06       Impact factor: 0.910

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  22 in total

1.  Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.

Authors:  Fei Li; Qing Li; Yubo Liu; Jing Han; Wei Zheng; Yini Huang; Xueyi Zheng; Longhui Cao; Jian-Hua Zhou
Journal:  Eur Radiol       Date:  2019-07-11       Impact factor: 5.315

Review 2.  Using LI-RADS With Contrast-Enhanced Ultrasound.

Authors:  Shuchi K Rodgers; David T Fetzer; Yuko Kono
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 3.  Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors:  Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

4.  High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients.

Authors:  F Giangregorio; M Garolfi; E Mosconi; L Ricevuti; M G Debellis; M Mendozza; C Esposito; E Vigotti; D Cadei; D Abruzzese
Journal:  J Ultrasound       Date:  2022-10-13

5.  In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles.

Authors:  Hua Zhang; Elizabeth S Ingham; M Karen J Gagnon; Lisa M Mahakian; Jingfei Liu; Josquin L Foiret; Juergen K Willmann; Katherine W Ferrara
Journal:  Biomaterials       Date:  2016-11-21       Impact factor: 12.479

6.  Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Xiao-Wen Huang; Yang Huang; Li-da Chen; Zhu Wang; Zheng Yang; Jin-Ya Liu; Xiao-Yan Xie; Ming-De Lu; Shun-Li Shen; Wei Wang
Journal:  J Med Ultrason (2001)       Date:  2017-10-20       Impact factor: 1.314

7.  Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.

Authors:  Juanjuan Zhang; Yanyan Yu; Ying Li; Lunshou Wei
Journal:  Oncotarget       Date:  2017-08-07

8.  A Nomogram Based on Combining Clinical Features and Contrast Enhanced Ultrasound LI-RADS Improves Prediction of Microvascular Invasion in Hepatocellular Carcinoma.

Authors:  Hang Zhou; Jiawei Sun; Tao Jiang; Jiaqi Wu; Qunying Li; Chao Zhang; Ying Zhang; Jing Cao; Yu Sun; Yifan Jiang; Yajing Liu; Xianli Zhou; Pintong Huang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

Review 9.  Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound.

Authors:  Junghoan Park; Jeong Min Lee; Tae-Hyung Kim; Jeong Hee Yoon
Journal:  Clin Mol Hepatol       Date:  2021-12-27

10.  Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?

Authors:  Jia-Yan Huang; Jia-Wu Li; Wen-Wu Ling; Tao Li; Yan Luo; Ji-Bin Liu; Qiang Lu
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.